[1]
M. Cedeño-Arias, C. E. Rengifo, M. Ramos-Suzarte, R. Blanco Santana, E. Rengifo, and F. F. Nogales, “IOR C2: A Tumor Associated Antigen as Potential Target for Immunotherapy in Epithelial Ovarian Cancer”, acta, vol. 22, no. 3, pp. 239-247, May 2013.